{"id":1050,"date":"2024-03-05T09:28:54","date_gmt":"2024-03-05T09:28:54","guid":{"rendered":"https:\/\/amm-journal.org\/?p=1050"},"modified":"2024-03-05T09:28:54","modified_gmt":"2024-03-05T09:28:54","slug":"g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases","status":"publish","type":"post","link":"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/","title":{"rendered":"G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases"},"content":{"rendered":"

Announcing a new publication for Acta Materia Medica<\/em> journal. G protein-coupled receptors (GPCRs) are important, potential drug targets for the treatment of metabolic disorders, such as obesity. GPCRs crosstalk with several transducers, including heterotrimeric G proteins, GPCR kinases (GRKs), and \u03b2-arrestins. GPCR-biased agonism has raised the potential of novel drug development to preferentially activate therapeutic signaling pathways over pathways that lead to unwanted side effects. The obesity epidemic and its metabolic complications continue to be a major global public health threat but effective treatments are limited. The accelerated development of structural techniques, like X-ray crystallography and cryo-electron microscopy, has paved the way to understanding how biased agonism measured at GPCRs results in specific downstream physiologic responses. The authors of this article summarize well-validated GPCR targets and outline several new and promising receptors for obesity treatment. The significance of deciphering the role of GPCRs in obesity pathology and biased signaling for drug development are highlighted.<\/p>\n

https:\/\/www.scienceopen.com\/hosted-document?doi=10.15212\/AMM-2023-0041<\/a><\/p>\n

Acta Materia Medica<\/em> welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.<\/p>\n

Submission Process<\/strong><\/p>\n

Submissions to Acta Materia Medica<\/em> are made using ScholarOne, the online submission and peer review system. Registration and access are available at https:\/\/mc04.manuscriptcentral.com\/ammed<\/a><\/p>\n

Queries about the journal can be sent to editorialoffice@amm-journal.org.<\/p>\n

Please visit https:\/\/amm-journal.org\/<\/a> to learn more about the journal.<\/p>\n

Editorial Board:<\/strong> https:\/\/amm-journal.org\/index.php\/editorial-board\/<\/a><\/p>\n

There are no author submission or article processing fees.<\/p>\n

Follow Acta Materia Medica <\/em><\/strong>on Twitter https:\/\/twitter.com\/AMM_journal<\/a>; Facebook<\/a> (https:\/\/www.facebook.com\/AMMjournal<\/a>)<\/p>\n

eISSN <\/strong>2737-7946<\/p>\n

Shengnan Shen, Qiwen Liao and Liwei Gu et al. G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases.\u00a0Acta Materia Medica.\u00a0<\/em>2024. Vol. 3(1):31-45. DOI: 10.15212\/AMM-2023-0041<\/p>\n","protected":false},"excerpt":{"rendered":"

Announcing a new publication for Acta Materia Medica journal. G protein-coupled receptors (GPCRs) are important, potential drug targets for the treatment of metabolic disorders, such as obesity. GPCRs crosstalk with several transducers, including heterotrimeric G proteins, GPCR kinases (GRKs), and \u03b2-arrestins. GPCR-biased agonism has raised the potential of novel drug development to preferentially activate therapeutic […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-1050","post","type-post","status-publish","format-standard","hentry","category-news-and-events"],"yoast_head":"\nG protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases - AMM Journal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases - AMM Journal\" \/>\n<meta property=\"og:description\" content=\"Announcing a new publication for Acta Materia Medica journal. G protein-coupled receptors (GPCRs) are important, potential drug targets for the treatment of metabolic disorders, such as obesity. GPCRs crosstalk with several transducers, including heterotrimeric G proteins, GPCR kinases (GRKs), and \u03b2-arrestins. GPCR-biased agonism has raised the potential of novel drug development to preferentially activate therapeutic […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"AMM Journal\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-05T09:28:54+00:00\" \/>\n<meta name=\"author\" content=\"Compuscript\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Compuscript\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/03\\\/05\\\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/03\\\/05\\\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\\\/\"},\"author\":{\"name\":\"Compuscript\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\"},\"headline\":\"G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases\",\"datePublished\":\"2024-03-05T09:28:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/03\\\/05\\\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\\\/\"},\"wordCount\":316,\"commentCount\":0,\"articleSection\":[\"News and Events\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/03\\\/05\\\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/03\\\/05\\\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\\\/\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/03\\\/05\\\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\\\/\",\"name\":\"G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases - AMM Journal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\"},\"datePublished\":\"2024-03-05T09:28:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/03\\\/05\\\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/03\\\/05\\\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/03\\\/05\\\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/amm-journal.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/\",\"name\":\"AMM Journal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/amm-journal.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\",\"name\":\"Compuscript\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"caption\":\"Compuscript\"},\"sameAs\":[\"https:\\\/\\\/amm-journal.org\"],\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/author\\\/ammjadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases - AMM Journal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/","og_locale":"en_GB","og_type":"article","og_title":"G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases - AMM Journal","og_description":"Announcing a new publication for Acta Materia Medica journal. G protein-coupled receptors (GPCRs) are important, potential drug targets for the treatment of metabolic disorders, such as obesity. GPCRs crosstalk with several transducers, including heterotrimeric G proteins, GPCR kinases (GRKs), and \u03b2-arrestins. GPCR-biased agonism has raised the potential of novel drug development to preferentially activate therapeutic […]","og_url":"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/","og_site_name":"AMM Journal","article_published_time":"2024-03-05T09:28:54+00:00","author":"Compuscript","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Compuscript","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/#article","isPartOf":{"@id":"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/"},"author":{"name":"Compuscript","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67"},"headline":"G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases","datePublished":"2024-03-05T09:28:54+00:00","mainEntityOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/"},"wordCount":316,"commentCount":0,"articleSection":["News and Events"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/","url":"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/","name":"G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases - AMM Journal","isPartOf":{"@id":"https:\/\/amm-journal.org\/#website"},"datePublished":"2024-03-05T09:28:54+00:00","author":{"@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67"},"breadcrumb":{"@id":"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/amm-journal.org\/index.php\/2024\/03\/05\/g-protein-coupled-receptor-biased-signaling-potential-drug-discovery-to-facilitate-treatment-of-metabolic-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/amm-journal.org\/"},{"@type":"ListItem","position":2,"name":"G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases"}]},{"@type":"WebSite","@id":"https:\/\/amm-journal.org\/#website","url":"https:\/\/amm-journal.org\/","name":"AMM Journal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amm-journal.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67","name":"Compuscript","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","caption":"Compuscript"},"sameAs":["https:\/\/amm-journal.org"],"url":"https:\/\/amm-journal.org\/index.php\/author\/ammjadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/comments?post=1050"}],"version-history":[{"count":1,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1050\/revisions"}],"predecessor-version":[{"id":1051,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1050\/revisions\/1051"}],"wp:attachment":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media?parent=1050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/categories?post=1050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/tags?post=1050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}